Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma
Clinical trial NCT02252172 · COMPLETED
Trial details
- NCT number
- NCT02252172
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-16
- Primary completion
- 2018-09-24
- Enrollment
- 737
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.